On March 28, shares in the First Capital Inc. company were selling at $25.2.
First Capital Inc. employs 184 people and has reported $13,190,000 in income as of March 28.
In the fluctuating stock market, healthcare and technology stocks are viewed as the safest bets for long-term gains.
Besty Kuekcer with Benzinga.com said healthcare-related stocks, such as hospital conglomerates and insurance companies, have weathered numerous economic crises and still make a profit, meaning they’re a stable investment.
While technology stocks can be more risky, given the boom-bust nature of new tech companies, Kuecker recommended a diverse portfolio of tech companies to strike it big when companies succeed or sell to other larger companies.
For short-term investments, Kuecker recommended “consumer discretionary” stocks, which are sensitive to economic changes but can rise greatly on the back of a strong economy.
Nothing in this article is to be assumed as financial advice.
Individual companies can have several different types of shares across many stock markets. It is possible for different types of shares to see different results on the market.
| Company Name | % of Change in Last Year | Selling Price |
|---|---|---|
| Edgemode Inc | 15,900% | $0.016 |
| Arvana Inc. | 646.27% | $1 |
| Biomea Fusion Inc. | 588.57% | $30.71 |
| Digital Brand Media & Marketing Group Inc. | 436.36% | $0.0059 |
| 89Bio Inc. | 322.53% | $16.69 |
| Ardelyx Inc. | 298.11% | $4.22 |
| Cabaletta Bio Inc. | 267.8% | $7.54 |
| Aehr Test Systems | 240.85% | $35.38 |
| Awaysis Capital Inc | 240% | $0.51 |
| Enliven Therapeutics Inc | 217.43% | $23.49 |
| Elf Beauty Inc. | 215.68% | $79.71 |
| Bellerophon Therapeutics Inc. | 211.3% | $7.44 |
| Cannabis Suisse Corp. | 200% | $0.069 |
| Atlas Lithium Corp | 189.52% | $17.48 |
| Immunovant Inc. | 185.54% | $15.99 |
| Cymabay Therapeutics Inc. | 180% | $8.82 |
| CVD Equipment Corp. | 176.66% | $12.09 |
| Akero Therapeutics Inc. | 162.11% | $38.32 |
| Biostem Technologies Inc | 161.19% | $3.5 |
| Bioxytran Inc | 160.43% | $0.4196 |
| Bioxytran Inc | 160.43% | $0.4196 |
| CECO Environmental Corp | 154.17% | $14.31 |
| Compass Therapeutics Inc. | 152% | $3.15 |
| International Seaways Inc. | 141.05% | $42.84 |
| Earth Science Tech Inc. | 140% | $0.036 |
| Asure Software Inc. | 137.5% | $14.25 |
| Vita Coco Company Inc. | 131.14% | $20.04 |
| Assertio Holdings Inc. | 128.47% | $6.26 |
| Flux Power Holdings Inc. | 107.72% | $5.11 |
| BioVie Inc. | 105.48% | $8.63 |
| Catalyst Pharmaceuticals Inc. | 105.14% | $16.37 |
| Agilysys Inc. | 100.99% | $81.44 |
| Bion Environmental Technologies Inc. | 98% | $1.78 |
| Arcellx Inc | 97.2% | $30.25 |
| Intapp Inc. | 95.8% | $42.86 |
| Amylyx Pharmaceuticals Inc | 90.57% | $30.51 |
| Cadiz Inc. | 88.26% | $4.01 |
| Bel Fuse Inc. | 86.97% | $34.57 |
| Bel Fuse Inc. | 86.97% | $34.57 |
| BrightRock Gold Corp. | 84.69% | $0.1568 |
| Adeia Inc | 84.09% | $8.37 |
| Bowman Consulting Group Ltd. | 84.06% | $28.75 |
| Actinium Pharmaceuticals Inc. | 83% | $9.04 |
| ADMA Biologics Inc. | 82.39% | $3.21 |
| Aaon Inc. | 82.02% | $94.98 |
| American Realty Investors Inc. | 81.18% | $26.17 |
| Ambac Financial Group Inc. | 79.59% | $14.87 |
| Geron Corp. | 79.34% | $2.17 |
| Aldeyra Therapeutics Inc. | 76.98% | $9.15 |
| Aldeyra Therapeutics Inc. | 76.98% | $9.15 |